Friday, July 31, 2026

Securitize Expands Regulatory Reach: What Does RIA Registration Mean for Tokenized Assets in 2026?

Securitize registers as a Registered Investment Advisor, enhancing its services for institutional investors in tokenized assets.

North Korea Ramps Up Efforts to Protect Crops from Flood Damage

North Korea urges strong measures to prevent water damage to crops as harvest season approaches, highlighting urgent agricultural needs.

Unlocking Global Sales: How South Korean SMEs Can Thrive on Amazon and Shopee in 2026

The government is accelerating support for small businesses to expand online sales abroad, enhancing marketing and logistics efforts.

Tag: cell therapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Revolutionary SperoQure: How JNPMEDI is Transforming Osteoarthritis Treatment in 2026

JNPMEDI will support clinical trials for speroQure, a novel cell therapy for osteoarthritis, ensuring a smooth and effective process.

Matica Bio Launches Open Access Platform: A Game Changer for Gene Therapy in 2026

Matica Bio launches an open CDMO platform for gene therapy, enhancing client control and streamlining production with Cirsium Biosciences.

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.